MDAX | Jotup

EQS-News: Evotec SE reports first half-year 2023 results on 29 August 2023

Retrieved on:

Tuesday, August 22, 2023

ISIN, Webcast, Frankfurt Stock Exchange, PIN, EDT, CEST, EVO, MDAX, BST

Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) will announce its financial results for the first half-year of 2023 on Tuesday, 29 August 2023.

Key Points:

Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) will announce its financial results for the first half-year of 2023 on Tuesday, 29 August 2023.
The Company is going to hold a conference call to discuss the results as well as provide an update on its performance.
Time: 2.00 pm CEST (01.00 pm BST, 08.00 am EDT)
To join via phone, please pre-register via this link .
You will then receive a confirmation email with dedicated dial-in details such as telephone number, access code and PIN to access the call.

EQS-News: ENCAVIS AG demonstrates the resilience of its business model in turbulent times with stable revenue and stable earnings per share

Retrieved on:

Tuesday, August 22, 2023

The Asset Management Segment increased revenue by more than 12% in the first half of 2023 to EUR 7.5 million (previous year: EUR 6.7 million).

Key Points:

The Asset Management Segment increased revenue by more than 12% in the first half of 2023 to EUR 7.5 million (previous year: EUR 6.7 million).
“Our business model has once again proven its resilience even in these turbulent and difficult to plan times.
We owe stable revenue and equally stable earnings per share to our consistent growth path without losing focus on future returns.
Operating earnings per share*) are expected to exceed EUR 0.60 and thus slightly exceed the previous year's figure (2022: EUR 0.60).

EQS-News: ENCAVIS AG and Allego enlarge their 10-year PPA in Germany to supply Electric Vehicle drivers with 100% Renewable Energy

Retrieved on:

Tuesday, August 8, 2023

EV, Electricity, Electric vehicle, Primary energy, Kilowatt-hour, Deutsch, Vehicle registration plates of Nepal, Renewable energy, Power purchase agreement, CIO, Heat, Transport, PPA, NYSE, MDAX, Borrentin

With 100% Renewable Energy from Encavis’ solar parks in Groß Behnitz (25 MW/Brandenburg) and now also in Borrentin (105 MW/Mecklenburg-Western Pomerania), making it Allego’s most extensive clean energy agreement to date.

Key Points:

With 100% Renewable Energy from Encavis’ solar parks in Groß Behnitz (25 MW/Brandenburg) and now also in Borrentin (105 MW/Mecklenburg-Western Pomerania), making it Allego’s most extensive clean energy agreement to date.
The two solar parks will supply Allego’s charging network with more than 100 GWh of Renewable Electricity and the associated certificates of origin.
"In order to successfully shape the energy transition, it is essential to work with companies that have serious commitments to Renewable Energy, like Allego.
This PPA represents Encavis' and Allego’s shared commitment to sustainable innovation and accelerating the electrification of transportation in Germany.

EQS-News: Aurubis AG: Aurubis with stable operating result in the first nine months of 2022/23

Retrieved on:

Monday, August 7, 2023

In the first nine months, the company generated operating earnings before taxes (EBT) of € 406 million (previous year adjusted: € 426 million).

Key Points:

In the first nine months, the company generated operating earnings before taxes (EBT) of € 406 million (previous year adjusted: € 426 million).
In Q3, which ended on June 30, 2023, the multimetal company generated a roughly 20 % increase in operating EBT to € 115 million (previous year adjusted: € 95 million).
“In the third quarter, we again demonstrated that Aurubis is continuing on its successful path and generating solid results,” Aurubis CEO Roland Harings said.
IFRS consolidated earnings* before taxes (EBT) were € 207 million (previous year: € 793 million) in the first nine months of 2022/23.

EQS-News: Aurubis AG: H2-ready: Aurubis investing in hydrogen-capable anode furnaces in the Hamburg plant

Retrieved on:

Friday, August 4, 2023

Hamburg, August 4, 2023 – Aurubis already produces copper with less than half the average global carbon footprint today.

Key Points:

Hamburg, August 4, 2023 – Aurubis already produces copper with less than half the average global carbon footprint today.
The conversion in the Hamburg plant will be carried out as part of the plant’s routine maintenance shutdown slated for spring 2024.
The new anode furnaces will play a vital role in the copper production process in Hamburg.
“By replacing the anode furnaces, we are achieving another milestone in our decarbonization strategy,” said Aurubis AG CEO Roland Harings.

EQS-News: Rational AG: Sales revenues up 23 percent to 561 million euros in the first half of 2023

Retrieved on:

Thursday, August 3, 2023

Social responsibility, Food, Tax, EBIT, Stainless steel, Movement, Investment, CFO, Growth, Hand, Many, MDAX, Tourism, Chemical, Rationality

Rational generated sales revenues of 278.3 million euros, 20 percent up on the figure for the second quarter of 2022 (2022: 232.4 million euros).

Key Points:

Rational generated sales revenues of 278.3 million euros, 20 percent up on the figure for the second quarter of 2022 (2022: 232.4 million euros).
After the first six months of 2023, sales revenues amounted to 560.8 million euros, 23 percent up on the previous year (2022: 457.7 million euros).
In the iVario product group, sales revenues of 57.8 million euros were slightly down on the previous year (62.6 million euros).
Cost of sales increased more slowly than sales revenues in the first half of the year, up around 17 percent to 246.0 million euros (2022: 210.5 million euros).

EQS-News: Redcare Pharmacy Q2 2023: While fast sales growth continues unabated at 46%, adj. EBITDA margin improved 5.3pp year over year to 3.2%. Company raises full-year guidance.

Retrieved on:

Tuesday, August 1, 2023

Partnership, International, Pharmacy, Sevenum, SHOP, Marketing, S&D, EUROPE, Annual, DACH, SDAX, NPS, EBITDA, Depreciation, Growth, MDAX, Pharmaceutical industry, Film industry, Retail, Lithium, Q2, EUR

Redcare Pharmacy Q2 2023: While fast sales growth continues unabated at 46%, adj.

Key Points:

Redcare Pharmacy Q2 2023: While fast sales growth continues unabated at 46%, adj.
Final figures show sales grew 46.2% year over year in Q2 to EUR 420 million (Q2 2022: EUR 287 million).
Non-Rx sales growth was confirmed at 27% in Q2 to EUR 323 million (Q2 2022: EUR 255 million).
In Q2 2023, adjusted S&D expenses were 19.3% of sales, or EUR 81.1 million (Q2 2022: 26.3% of sales, or EUR 75.5 million).

EQS-News: Nemetschek SE: First Half of 2023 on Plan – Continued Strong Growth in Subscription and SaaS in Q2 2023

Retrieved on:

Monday, July 31, 2023

This is reflected in the continued very strong growth of this revenue category as well as the continued strong performance of annual recurring revenue (ARR).

Key Points:

This is reflected in the continued very strong growth of this revenue category as well as the continued strong performance of annual recurring revenue (ARR).
In the first half of the year, the growth amounted to 42.7% (FX-adjusted: 43.2%) to EUR 132.0 million (H1-2022: EUR 92.5 million).
In Q2, Group revenue grew by 1.8% (FX-adjusted: 3.3%) to EUR 207.5 million despite the ongoing subscription and SaaS transition.
Revenue from subscription and SaaS continued to grow at a disproportionately high rate in Q2, with a currency-adjusted growth of almost 40%.

EQS-News: Evotec provides update on financial impact of cyber-attack

Retrieved on:

Thursday, July 27, 2023

Partnership, Frankfurt Stock Exchange, EDT, Novartis, EBITDA, PIN, Patient, Nature, CEST, ISIN, Webcast, BMS, Environment, EVO, MDAX, BST, Pharmaceutical industry, Evotec, Q2

Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) today announced that it is adjusting its guidance for the fiscal year 2023 due to the impact of the cyber-attack.

Key Points:

Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) today announced that it is adjusting its guidance for the fiscal year 2023 due to the impact of the cyber-attack.
However, due to the discovery of a criminal cyber-attack on 6 April 2023, productivity was affected throughout the entire second quarter.
In response to the criminal cyber-attack, Evotec took immediate action to contain and remediate the attack by taking its external-facing systems offline.
This was deemed necessary to protect all the Company’s partners and stakeholders and Evotec could ensure that integrity of scientific data remained unaffected.

EQS-News: ENCAVIS AG: SCOPE affirms Encavis AG’s investment grade issuer rating ‘BBB-‘, and the Outlook remains ‘Positive’

Retrieved on:

Thursday, July 27, 2023

Hamburg, 27 July 2023 – The Hamburg-based wind and solar park operator Encavis AG (Prime Standard; ISIN: DE0006095003, ticker symbol: ECV), listed on the MDAX of Deutsche Börse AG, and its financing subsidiary Encavis Finance BV have been rated again by the European rating agency SCOPE Ratings (SCOPE) affirming the investment grade issuer rating BBB-.

Key Points:

Hamburg, 27 July 2023 – The Hamburg-based wind and solar park operator Encavis AG (Prime Standard; ISIN: DE0006095003, ticker symbol: ECV), listed on the MDAX of Deutsche Börse AG, and its financing subsidiary Encavis Finance BV have been rated again by the European rating agency SCOPE Ratings (SCOPE) affirming the investment grade issuer rating BBB-.
Concurrently, SCOPE has affirmed the ratings for senior unsecured debt at BBB-, subordinated (hybrid) debt at BB and short-term debt at S-2.
SCOPE has the opinion that the decreasing share of subsidised projects will likely be compensated by growing outreach and improving granularity of Encavis’ own portfolio.
To see the updated issuer report, as well as the rating history including SCOPE's initial public rating on Encavis AG and its debt-issuing subsidiary Encavis Finance BV on March 18, 2019, please click: